Abstract
IFN-α and skin-infiltrating activated T lymphocytes have important roles in the pathogenesis of psoriasis. T cells from psoriatic patients display an increased sensitivity to IFN-α, but the pathological mechanisms behind the hyperresponsiveness to IFN-α remained unknown. In this study, we show that psoriatic T cells display deficient expression of the suppressor of cytokine signaling (SOCS)3 in response to IFN-α and a low baseline expression of the SH2-domain-containing protein-tyrosine phosphatase (SHP)-1 when compared with skin T cells from nonpsoriatic donors. Moreover, IFN-α-stimulated psoriatic T cells show enhanced activation of JAKs (JAK1 and TYK2) and signal transducers and activators of transcription. Increased expression of SOCS3 proteins resulting from proteasomal blockade partially inhibits IFN-α response. Similarly, forced expression of SOCS3 and SHP-1 inhibits IFN-α signaling in psoriatic T cells. In conclusion, our data suggest that loss of regulatory control is involved in the aberrant hypersensitivity of psoriatic T cells to IFN-α.
Original language | English |
---|---|
Pages (from-to) | 1590-1597 |
Number of pages | 8 |
Journal | Journal of Investigative Dermatology |
Volume | 130 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2010 |
Keywords
- Case-Control Studies
- Cell Line
- Humans
- Interferon-alpha/metabolism
- Janus Kinases/metabolism
- Protein Tyrosine Phosphatase, Non-Receptor Type 6/deficiency
- Psoriasis/metabolism
- STAT Transcription Factors/metabolism
- Signal Transduction/physiology
- Suppressor of Cytokine Signaling 3 Protein
- Suppressor of Cytokine Signaling Proteins/deficiency
- T-Lymphocytes/metabolism